Portable UV-C device to treat high flow of infectious aerosols generated during clinical respiratory care is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH/NCATS
Grant: Grant 5UL1TR001433-05a
NIH/NIAID
Grant: R01AI160706
NIH/NIDDK
Grant: R01DK130425
CRIPT (Center for Research on Influenza Pathogenesis and Transmission), a NIH NIAID funded Center of Excellence for Influenza Research and Response
Grant: (CEIRR, contract number 75N93021C00014),
Korea Health Industry 914 Development Institute (KHIDI) for research under the Biomedical Global Talent Nurturing Program
Grant: (HI22C2101).
NIAID
Grant: contract 75N93019C00046
NIAID NIH HHS
Grant: 75N93019C00046
NCATS NIH HHS
Grant: UL1 TR001433
NIAID NIH HHS
Grant: 75N93021C00014
NIAID NIH HHS
Grant: R21 AI176069
NIAID NIH HHS
Grant: R44 AI176894
NIAID NIH HHS
Grant: R21 AI180874
National Institutes of Health
Grant: 5R44AI176894-02
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
National Institutes of Health
Grant: 5UL1TR001433-05
MSHS Translational Science Hub
National Institutes of Health
Grant: 1R01DK130425-01
Experimental and natural SARS-CoV-2 infection of the human pancreas
National Institutes of Health
Grant: 5UL1TR001433-02
MSHS Translational Science Hub
National Institutes of Health
Grant: 5R01AI160706-04
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
National Institutes of Health
Grant: 5R21AI176069-02
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
National Institutes of Health
Grant: 5R21AI180874-02
Impact of mucosal adjuvanted vaccines on virus transmission in preclinical animal models for SARS-CoV-2 and influenza virus infection
FWCI
0.83
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals